Microarray expression analysis of genes and pathways involved in growth plate cartilage injury responses and bony

Carmen E Macsai1, Kristen R Georgiou, Bruce K Foster

  • 1Sansom Institute for Health Research, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia.

Bone
|March 6, 2012
PubMed

Insights

Bone bridge formation after growth plate injury causes deformities. This study identifies key molecular pathways, including Wnt and BMP signaling, involved in bone formation, offering potential therapeutic targets.

Area of Science:

  • Orthopedics and Regenerative Medicine
  • Molecular Biology
  • Skeletal Development

Background:

  • Growth plate cartilage injury can lead to bone bridge formation, resulting in limb length discrepancies and deformities.
  • Previous research identified cellular responses but lacked insight into the underlying molecular pathways regulating bone bridge formation.

Purpose of the Study:

  • To investigate the molecular pathways governing cellular events during bone bridge formation in a rat growth plate injury model.
  • To identify potential therapeutic targets for preventing bone deformities post-injury.

Main Methods:

  • Utilized a rat growth plate injury model.
  • Collected tissue samples over the time-course of bone bridge formation.
  • Employed laser capture microdissection, Affymetrix microarray gene expression analysis, Real Time PCR, and immunohistochemical analyses.

Main Results:

  • Identified four major functional groupings of differentially expressed genes involved in skeletal development.
  • Highlighted the roles of Wnt signaling (e.g., SFRP1, β-catenin) and Bone Morphogenetic Protein (BMP) signaling (e.g., BMP-2, Chrd).
  • Confirmed gene expression changes using Real Time PCR and immunohistochemistry.

Conclusions:

  • The study provides novel insights into the molecular pathways, including Wnt and BMP signaling, that regulate bone formation after growth plate injury.
  • These findings highlight potential therapeutic targets to inhibit bone bridge formation and prevent associated deformities.